American Vanguard Corporation (NYSE:AVD – Get Free Report) Director Patrick Gottschalk bought 25,000 shares of American Vanguard stock in a transaction that occurred on Tuesday, May 19th. The shares were acquired at an average price of $2.70 per share, for a total transaction of $67,500.00. Following the acquisition, the director directly owned 191,705 shares in the company, valued at approximately $517,603.50. This represents a 15.00% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
American Vanguard Stock Performance
NYSE:AVD opened at $2.67 on Wednesday. The company has a current ratio of 2.32, a quick ratio of 1.41 and a debt-to-equity ratio of 1.39. The firm has a market capitalization of $76.30 million, a price-to-earnings ratio of -1.68 and a beta of 1.48. The firm’s fifty day simple moving average is $2.85 and its 200 day simple moving average is $3.95. American Vanguard Corporation has a twelve month low of $2.05 and a twelve month high of $5.92.
American Vanguard (NYSE:AVD – Get Free Report) last posted its earnings results on Wednesday, May 6th. The basic materials company reported ($0.14) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.08). The business had revenue of $123.57 million for the quarter, compared to analyst estimates of $120.00 million. American Vanguard had a negative net margin of 8.71% and a negative return on equity of 4.13%.
Hedge Funds Weigh In On American Vanguard
Analyst Ratings Changes
Separately, Weiss Ratings lowered shares of American Vanguard from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday. One equities research analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $12.00.
Check Out Our Latest Research Report on AVD
About American Vanguard
American Vanguard Corporation (NYSE: AVD) is a developer, manufacturer and marketer of specialty chemical products for crop protection, turf and ornamental care, and public health pest control. Headquartered in Newport Beach, California, the company offers a portfolio of insecticides, herbicides, fungicides and rodenticides designed for use across agricultural, turf and urban pest management applications. Its research and development efforts focus on novel chemistries and formulation technologies that address emerging pest resistance and regulatory requirements.
The company’s product lines include emulsifiable concentrates, wettable powders, granular formulations, baits and liquid concentrates sold under proprietary brand names.
Featured Stories
- Five stocks we like better than American Vanguard
- HIVE Weaponizes Power for an AI Pivot
- A Deep Dive Into NVIDIA’s Latest Portfolio Moves
- Brady Corp Wires Up a Massive AI-Powered Breakout
- Why Home Depot’s Sell-Off Could Become a Huge Opportunity
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.
